Golden State Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $114K | Buy |
256
+161
| +169% | +$71.7K | 0.01% | 452 |
|
|
2025
Q1 | $46.1K | Buy |
95
+4
| +4% | +$1.94K | 0.01% | 611 |
|
|
2024
Q4 | $36.6K | Buy |
+91
| New | +$36.6K | 0.01% | 639 |
|
|
2022
Q1 | – | Sell |
-961
| Closed | -$211K | – | 368 |
|
|
2021
Q4 | $211K | Buy |
+961
| New | +$211K | 0.04% | 347 |
|
|
2021
Q3 | – | Sell |
-1,065
| Closed | -$215K | – | 319 |
|
|
2021
Q2 | $215K | Buy |
+1,065
| New | +$215K | 0.05% | 273 |
|
|
2020
Q2 | – | Sell |
-71
| Closed | -$17K | – | 886 |
|
|
2020
Q1 | $17K | Buy |
+71
| New | +$17K | 0.01% | 533 |
|
|
2019
Q4 | – | Sell |
-71
| Closed | -$12K | – | 921 |
|
|
2019
Q3 | $12K | Hold |
71
| – | – | ﹤0.01% | 720 |
|
|
2019
Q2 | $13K | Hold |
71
| – | – | ﹤0.01% | 704 |
|
|
2019
Q1 | $13K | Buy |
+71
| New | +$13K | ﹤0.01% | 725 |
|